查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559455

肺活量计 - 市场考察、竞争格局、市场预测 (2030)

Spirometers - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

到2030年，全球肺活量计市场规模预计将达到 18.0166亿美元，2024-2030年预测期间年复合成长率为 4.65%。由于几个关键因素，预计市场将显着成长。首先，包括慢性阻塞性肺病 (COPD) 和气喘在内的呼吸系统疾病负担的增加强调了对有效诊断和监测工具的需求，增加了对肺活量计的需求。吸烟人数的迅速增加进一步加剧了呼吸道疾病，并增加了定期进行肺功能检查以控制和预防疾病进展的需求。此外，人们对呼吸系统健康意识的提高和广泛筛检计画的实施促进早期检测和干预，并促进采用肺活量测定法作为标准诊断工具。此外，随着主要市场参与者不断创新和推出具有改进功能和技术的先进肺活量测定设备，市场随着产品发布和批准的增加而增强。预计这些因素将共同促进2024-2030年预测期内肺活量计市场的扩张。

肺活量计市场动态

根据Australian Institute of Health and Welfare提供的最新资料，预计2022年澳洲约有850万人 (34%) 患有慢性呼吸道疾病。

此外，根据Global Burden of Disease (2023年) 的最新资料，全球约有每20 人中就有 1 人患有慢性呼吸道疾病。

此外，根据世界卫生组织 (WHO) 提供的最新资料 (2023年) ，吸烟是慢性阻塞性肺病的主要原因，慢性阻塞性肺病是一种常见的肺部疾病，会导致呼吸困难，并已夺走了许多人的生命。约 3.92亿人患有慢性阻塞性肺病，其中约 75%生活在低收入和中等收入国家。在高收入国家，吸烟占 COPD 病例的70%以上。

由于吸烟和环境因素导致呼吸系统疾病的盛行率增加，对肺活量计的需求不断成长，这对于将药物直接输送到肺部以有效缓解症状和进行疾病管理非常重要。

此外，根据 GLOBOCAN 最新提供的资料，预计2022年全球将新增气管癌、支气管癌和肺癌病例 248万例，到2045年将新增 425万例。慢性阻塞性肺病是一种主要由吸烟引起的进行性呼吸道疾病，需要定期评估肺功能来控制症状并追踪疾病进展。随着慢性阻塞性肺病发病率的增加，医疗保健提供者越来越依赖肺活量计来评估肺活量和气流阻塞，这使得这些设备对于诊断和持续管理非常重要。同样，吸烟率的迅速增加导致包括慢性阻塞性肺病在内的呼吸系统疾病的发生率增加，增加了对肺活量测定的需求。吸烟者和前吸烟者通常是定期肺功能筛检的候选人，以发现早期损伤迹象并防止进一步恶化。

此外，该公司策略性地扩大其市场占有率，并透过扩大肺活量计生产和获得监管部门的批准来推动进一步成长。例如，2024年 1月，NuvoAir Medical 宣布其创新的Air Next 肺活量计获得正式 510 (k) 许可，可作为完整的肺活量计在家庭中使用。此次批准使 NuvoAir 能够扩大其临床业务，并确保不遗漏任何患有心臟病或肺病的患者。

此外，肺活量测定法临床试验的成功为市场带来了巨大动力，增加了成长前景并鼓励增加兴趣和投资。例如，2023年1月，开发实证数位生物标记的医疗科技公司Koneksa宣布启动临床试验。本研究比较了家用移动肺活量测定法和使用数位生物标记的诊所肺量测定法对接受长效 β 受体促效剂 (LABA) 治疗的中度气喘患者的治疗效果。

因此，上述因素可能会在预测期内推动肺活量计市场的发展。

然而，峰值流量计、二氧化碳计、影像技术和脉搏血氧计等替代设备的出现可能会阻碍未来肺活量计市场的发展。

本报告研究和分析了全球肺活量计市场，提供了每个地区的市场规模和预测、过去三年的产品/技术发展以及每个细分市场的业绩和前景等资讯。

目录

第1章 肺活量计市场报告简介

第2章 肺活量计市场执行摘要

  • 市场概览

第3章 竞争态势

第4章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 肺活量计市场主要因素分析

  • 肺活量计市场驱动因素
  • 肺活量计市场的限制与挑战
  • 肺活量计市场机会

第6章 波特对肺活量计市场的五力分析

第7章 肺活量计市场评估

  • 依类型
    • 桌面
    • 携带式
  • 可移动性别
    • 体积测量
    • 流量测量
  • 依用途
    • 气喘
    • 慢性阻塞性肺病 (COPD)
    • 囊性纤维化
    • 其他
  • 依最终用户
    • 医院
    • 诊所
    • 居家护理
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第8章 肺活量计市场公司与产品概况

  • FUKUDA SANGYO CO., LTD.
  • Midmark Corporation
  • CHEST M.I., Inc.
  • KoKo PFT
  • Clarity Medical Pvt. Ltd.
  • COSMED srl
  • Jones Medical Instrument Company
  • Baxter
  • Teleflex Incorporated
  • VYAIRE MEDICAL, INC.
  • SIBEL, S.A.U.
  • Medikro Oy
  • ICU Medical Inc.
  • Vitalograph
  • Futuremed USA
  • Schiller AG
  • Aksia Group SGR S.p.A
  • CONTEC MEDICAL SYSTEMS CO., LTD.
  • NDD Medical Technologies
  • MGC DIAGNOSTICS CORPORATION

第9章 KOL观点

第10章 专案方法

第11章 关于 DelveInsight

第12章 免责声明，联络我们

Product Code: DIMDCL0092

Spirometers by Type (Table Top and Portable), Technology (Volume Measurement and Flow Measurement), Application (Asthma, Chronic Obstructive Pulmonary Disease [COPD], Cystic Fibrosis, and Others), End-User (Hospitals, Clinics, and Home Care), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of respiratory diseases, the surge in cigarette smoking, increasing awareness and screening programs, and increase in product launches and approvals by key market players across the globe.

The spirometer market will grow at a CAGR of 4.65% during the forecast period from 2024 to 2030 to reach USD 1,801.66 million by 2030. The market for spirometer is set to experience significant growth driven by several key factors. Firstly, the rising burden of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, underscores the need for effective diagnostic and monitoring tools, thereby increasing the demand for spirometer. The surge in cigarette smoking further exacerbates respiratory conditions, heightening the necessity for routine lung function testing to manage and prevent disease progression. Additionally, increasing awareness about respiratory health and the implementation of widespread screening programs are fostering early detection and intervention, which fuels the adoption of spirometry as a standard diagnostic tool. Furthermore, the market is being bolstered by a rise in product launches and approvals from key market players, who are continuously innovating and introducing advanced spirometry devices with improved features and technology. These factors are expected to collectively contribute to the expanding market for spirometer during the forecast period from 2024 to 2030.

Spirometers Market Dynamics:

According to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions.

Additionally, as per the recent data provided by the Global Burden of Disease (2023), approximately, 1 in 20 people globally suffers from chronic respiratory diseases.

Furthermore, as per the recent data provided by the World Health Organization (2023), smoking was a major cause of chronic obstructive pulmonary disease, a common lung condition that led to breathing difficulties and claimed over 3 million lives annually. Approximately 392 million people have COPD, with about 75% living in low- and middle-income countries. In high-income countries, tobacco smoking was responsible for over 70% of COPD cases.

As the incidence of respiratory disorders rises, driven largely by smoking and environmental factors, there is a heightened need for Spirometers, which are critical in delivering medication directly to the lungs for effective symptom relief and disease management.

Additionally, as per the recent data provided by GLOBOCAN, in 2022, globally the estimated new cases of trachea, bronchus, and lung cancer was 2.48 million, and the projections are expected to rise by 4.25 million by the year 2045. COPD, a progressive respiratory condition primarily caused by smoking, requires regular assessment of lung function to manage symptoms and track disease progression. As COPD prevalence rises, healthcare providers are increasingly relying on spirometer to evaluate lung capacity and airflow obstruction, making these devices essential for both diagnosis and ongoing management. Similarly, the surge in smoking rates contributes to a higher incidence of respiratory disorders, including COPD, which in turn drives the need for spirometry tests. Smokers and former smokers are often targeted for regular lung function screening to detect early signs of damage and prevent further deterioration.

Additionally, companies are amplifying their production of spirometer and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in January 2024, NuvoAir Medical announced that its innovative Air Next Spirometer had received formal 510(k) clearance for in-home use as a full spirometer. This approval allowed NuvoAir to scale and expand its clinical operations, ensuring that no patient with heart or lung conditions was left behind.

Moreover, the success of the clinical trial on spirometry gave a significant boost to the market, enhancing its growth prospects and driving increased interest and investment. For instance, in January 2023, Koneksa, a healthcare technology company that developed evidence-based digital biomarkers, announced the launch of a clinical study. The study compared the treatment effects of at-home mobile spirometry using digital biomarkers with in-clinic spirometry in patients with moderate asthma who were on long-acting beta-agonist (LABA) treatment.

Thus, the factors mentioned above are likely to boost the market of spirometers during the forecasted period.

However, the availability of alternative devices such as peak flow meters, capnometers, imagining techniques, and pulse oximeters may hinder the future market of spirometers.

Spirometers Market Segment Analysis:

Spirometers by Type (Table Top and Portable), Technology (Volume Measurement and Flow Measurement), Application (Asthma, Chronic Obstructive Pulmonary Disease [COPD], Cystic Fibrosis, and Others), End-User (Hospitals, Clinics, and Home Care), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the spirometer market, the portable spirometer is expected to hold a significant share in 2023. Portable spirometers are significantly boosting the overall spirometer market by enhancing accessibility and convenience for both patients and healthcare providers. These compact, handheld devices allow for real-time monitoring of lung function outside of traditional clinical settings, enabling patients to conduct tests at home or on the go. This increased accessibility is particularly valuable for managing chronic respiratory conditions like asthma and COPD, where regular monitoring is crucial. Portable spirometers also facilitate early detection and intervention, as patients can perform frequent tests without needing to visit a healthcare facility. Additionally, advancements in connectivity and integration with mobile health apps have enabled seamless data sharing with healthcare providers, improving remote patient management and personalized care. The growing adoption of portable spirometers reflects a shift towards more proactive and patient-centered healthcare, driving market growth as these devices become an integral part of routine respiratory health management.

In addition, new product launches are also likely to upsurge the global spirometer market during the forecasted period. For instance, in November 2021, Cipla announced the launch of Spirofy(R), India's first pneumotach-based portable, wireless spirometer, on World COPD Day. With this launch, the company aimed to revolutionize the diagnosis of Obstructive Airway Disease (OAD) and strengthen its position as a leader in lung health in India. This was part of the Company's LungAttack campaign, which sought to raise awareness about COPD and promote early diagnosis. Additionally, a shift in trend from table-top to portable devices will offer assistance in remote settings. This will increase the acceptance of spirometers for patients.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global spirometer market during the forecast period.

North America is expected to dominate the overall spirometer market:

North America is expected to account for the highest proportion of the spirometer market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease across the region, the increase in technological advancement, the surge in cigarette smoking, the increase in government initiatives coupled with increased awareness programs for respiratory disorders, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of Spirometers during the forecast period.

According to the recent data and stats provided by the American Lung Association (2024), in 2022, among children, asthma was more common in males accounting for 7.0% of the population in the United States and 5.4% in females. Additionally, as per the same source, asthma among adults is 10.8% for females and 6.5% for females across the region of the United States. Asthma management requires regular monitoring of lung function to adjust treatment plans and prevent exacerbations. Spirometers allow patients to track their lung function over time, providing critical data to healthcare providers for optimizing treatment strategies. This continuous need for monitoring drives the market for both in-clinic and portable spirometers.

Additionally, as per the data provided by the Centre for Disease Control and Prevention (2024), in 2022, 4.6% of adults had been diagnosed with COPD, emphysema, or chronic bronchitis in the United States.

Furthermore, as per the recent data and stats provided by the Centre for Disease Control and Prevention (2023), in 2021, approximately 11.5% of U.S. adults aged 18 and older smoked cigarettes, totaling around 28.3 million smokers. At that time, over 16 million Americans were living with a smoking-related disease. The spirometer market is significantly boosted by the increasing prevalence of chronic respiratory conditions such as COPD, emphysema, and chronic bronchitis, alongside rising smoking rates. These conditions, which are often exacerbated by smoking, require regular and accurate monitoring of lung function for effective management and treatment. Spirometers are essential tools for diagnosing and tracking these diseases, as they measure vital lung parameters such as airflow and lung volume.

The increasing number of product development activities in the region is further going to accelerate the growth of the spirometer market. For instance, in August 2021, Roundworks Technologies Private Limited announced the approval of 510(k) for its Alveoair Digital Spirometer. Alveoair(R) is a personal spirometer designed for asthma, COPD, cystic fibrosis, and ILD patients to help quantify their lung health.

Furthermore, in March 2023, Clario, a healthcare research technology company known for its endpoint technology solutions for clinical trials, announced a partnership with the technology startup ArtiQ. This collaboration aimed to improve the accuracy of respiratory clinical trials that require spirometry data. The partnership allowed for AI-based reviews of spirometry data collected on the Clario platform.

Therefore, the above-mentioned factors are expected to bolster the growth of the spirometer market in North America during the forecast period.

Spirometers Market Key Players:

Some of the key market players operating in the Spirometers market include FUKUDA SANGYO CO., LTD., Midmark Corporation, CHEST M.I., Inc., KoKo PFT, Clarity Medical Pvt. Ltd., COSMED srl, Jones Medical Instrument Company, Baxter, Teleflex Incorporated, VYAIRE MEDICAL, INC., SIBEL, S.A.U., Medikro Oy, ICU Medical Inc., Vitalograph, Futuremed USA, Schiller AG, Aksia Group SGR S.p.A, CONTEC MEDICAL SYSTEMS CO., LTD, NDD Medical Technologies, MGC DIAGNOSTICS CORPORATION, and others.

Recent Developmental Activities in the Spirometers Market:

  • In September 2022, RxCap, Inc., a cloud-based remote monitoring company, and ZEPHYRx LLC, a provider of remote respiratory monitoring solutions, announced their partnership to integrate ZEPHYRx's cloud spirometry platform with RxCap's remote monitoring platform.
  • In March 2022, KoKo, LLC, a software developer and medical device manufacturer, and MAGNET group, a purchasing organizations (GPO) company signed a three-year partnership contract that allows access to all of KoKo's "gold standard" lung function diagnostics and software for spirometry, diffusion capacity, and PFT.

Key Takeaways From the Spirometers Market Report Study:

  • Market size analysis for current spirometer size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the spirometer market.
  • Various opportunities available for the other competitors in the spirometer market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current spirometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for spirometer market growth in the coming future?

Target Audience who can be Benefited From This Spirometers Market Report Study:

  • Spirometers product providers
  • Research organizations and consulting companies
  • Spirometers -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in spirometer
  • Various end-users who want to know more about the spirometer market and the latest technological developments in the spirometer market.

Frequently Asked Questions for the Spirometers Market:

1. What are spirometers?

The spirometer is a medical device that is used for performing spirometry tests to examine the function of the lungs. It is a very valuable tool for studying multiple respiratory problems such as asthma, chronic obstructive pulmonary disease (COPD), and others. It is also used to evaluate possible occupational pulmonary disorders and can be used to test lung functioning before surgery.

2. What is the market for spirometers?

The spirometer market will grow at a CAGR of 4.65% during the forecast period from 2024 to 2030 to reach USD 1,801.66 million by 2030.

3. What are the drivers for the spirometer market?

The spirometer market is set to experience significant growth driven by several key factors. Firstly, the rising burden of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, underscores the need for effective diagnostic and monitoring tools, thereby increasing the demand for spirometers. The surge in cigarette smoking further exacerbates respiratory conditions, heightening the necessity for routine lung function testing to manage and prevent disease progression. Additionally, increasing awareness about respiratory health and the implementation of widespread screening programs are fostering early detection and intervention, which fuels the adoption of spirometry as a standard diagnostic tool. Furthermore, the market is being bolstered by a rise in product launches and approvals from key market players, who are continuously innovating and introducing advanced spirometry devices with improved features and technology. These factors are expected to collectively contribute to the expanding market for spirometers during the forecast period from 2024 to 2030.

4. Who are the key players operating in the spirometer market?

Some of the key market players operating in the Spirometers market include FUKUDA SANGYO CO., LTD., Midmark Corporation, CHEST M.I., Inc., KoKo PFT, Clarity Medical Pvt. Ltd., COSMED srl, Jones Medical Instrument Company, Baxter, Teleflex Incorporated, VYAIRE MEDICAL, INC., SIBEL, S.A.U., Medikro Oy, ICU Medical Inc., Vitalograph, Futuremed USA, Schiller AG, Aksia Group SGR S.p.A, CONTEC MEDICAL SYSTEMS CO., LTD, NDD Medical Technologies, MGC DIAGNOSTICS CORPORATION, and others.

5. Which region has the highest share in the spirometer market?

North America is expected to account for the highest proportion of the spirometer market in 2023, out of all regions. This can be ascribed to the increasing prevalence of respiratory disease across the region, the increase in technological advancement, the surge in cigarette smoking, the increase in government initiatives coupled with increased awareness programs for respiratory disorders, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of Spirometers during the forecast period.

Table of Contents

1. Spirometers Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Spirometers Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Spirometers Market Key Factors Analysis

  • 5.1. Spirometers Market Drivers
    • 5.1.1. The rising burden of chronic respiratory diseases
    • 5.1.2. The surge in cigarette smoking
    • 5.1.3. Increasing awareness and screening programs
    • 5.1.4. Increase in product launches and approvals by key market players across the globe.
  • 5.2. Spirometers Market Restraints and Challenges
    • 5.2.1. The availability of alternative devices such as peak flow meters, capnometers, imagining techniques, and pulse oximeters
  • 5.3. Spirometers Market Opportunities
    • 5.3.1. The increase in the shift towards home-based healthcare solutions
    • 5.3.2. Integration of digital health and artificial intelligence

6. Spirometers Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Spirometers Market Assessment

  • 7.1. By Type
    • 7.1.1. Table Top
    • 7.1.2. Portable
  • 7.2. By Portability
    • 7.2.1. Volume Measurement
    • 7.2.2. Flow Measurement
  • 7.3. By Application
    • 7.3.1. Asthma
    • 7.3.2. Chronic Obstructive Pulmonary Disease (COPD)
    • 7.3.3. Cystic Fibrosis
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Homecare
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Spirometers Market Size in USD Million (2021-2030)
      • 7.5.1.2. Canada Spirometers Market Size in USD Million (2021-2030)
      • 7.5.1.3. Mexico Spirometers Market Size in USD Million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Spirometers Market Size in USD Million (2021-2030)
      • 7.5.2.2. Germany Spirometers Market Size in USD Million (2021-2030)
      • 7.5.2.3. United Kingdom Spirometers Market Size in USD Million (2021-2030)
      • 7.5.2.4. Italy Spirometers Market Size in USD Million (2021-2030)
      • 7.5.2.5. Spain Spirometers Market Size in USD Million (2021-2030)
      • 7.5.2.6. Rest of Europe Spirometers Market Size in USD Million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Spirometers Market Size in USD Million (2021-2030)
      • 7.5.3.2. Japan Spirometers Market Size in USD Million (2021-2030)
      • 7.5.3.3. India Spirometers Market Size in USD Million (2021-2030)
      • 7.5.3.4. Australia Spirometers Market Size in USD Million (2021-2030)
      • 7.5.3.5. South Korea Spirometers Market Size in USD Million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Spirometers Market Size in USD Million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Spirometers Market Size in USD Million (2021-2030)
      • 7.5.4.2. Africa Spirometers Market Size in USD Million (2021-2030)
      • 7.5.4.3. South America Spirometers Market Size in USD Million (2021-2030)

8. Spirometers Market Company and Product Profiles

  • 8.1. FUKUDA SANGYO CO., LTD.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Midmark Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. CHEST M.I., Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. KoKo PFT
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Clarity Medical Pvt. Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. COSMED srl
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Jones Medical Instrument Company
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Baxter
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Teleflex Incorporated
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. VYAIRE MEDICAL, INC.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. SIBEL, S.A.U.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Medikro Oy
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. ICU Medical Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Vitalograph
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Futuremed USA
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Schiller AG
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Aksia Group SGR S.p.A
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. CONTEC MEDICAL SYSTEMS CO., LTD.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. NDD Medical Technologies
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. MGC DIAGNOSTICS CORPORATION
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Spirometers Market in Global (2021-2030)
  • Table 3: Spirometers Market in Global by Type (2021-2030)
  • Table 4: Spirometers Market in Global by Technology (2021-2030)
  • Table 5: Spirometers Market in Global by Application (2021-2030)
  • Table 6: Spirometers Market in Global by End-User (2021-2030)
  • Table 7: Spirometers Market in Global by Geography (2021-2030)
  • Table 8: Spirometers Market in North America (2021-2030)
  • Table 9: Spirometers Market in the United States (2021-2030)
  • Table 10: Spirometers Market in Canada (2021-2030)
  • Table 11: Spirometers Market in Mexico (2021-2030)
  • Table 12: Spirometers Market in Europe (2021-2030)
  • Table 13: Spirometers Market in France (2021-2030)
  • Table 14: Spirometers Market in Germany (2021-2030)
  • Table 15: Spirometers Market in United Kingdom (2021-2030)
  • Table 16: Spirometers Market in Italy (2021-2030)
  • Table 17: Spirometers Market in Spain (2021-2030)
  • Table 18: Spirometers Market in the Rest of Europe (2021-2030)
  • Table 19: Spirometers Market in Asia-Pacific (2021-2030)
  • Table 20: Spirometers Market in China (2021-2030)
  • Table 21: Spirometers Market in Japan (2021-2030)
  • Table 22: Spirometers Market in India (2021-2030)
  • Table 23: Spirometers Market in Australia (2021-2030)
  • Table 24: Spirometers Market in South Korea (2021-2030)
  • Table 25: Spirometers Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Spirometers Market in the Rest of the World (2021-2030)
  • Table 27: Spirometers Market in the Middle East (2021-2030)
  • Table 28: Spirometers Market in Africa (2021-2030)
  • Table 29: Spirometers Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Spirometers Market in Global (2021-2030)
  • Figure 3: Spirometers Market in Global by Type (2021-2030)
  • Figure 4: Spirometers Market in Global by Technology (2021-2030)
  • Figure 5: Spirometers Market in Global by Application (2021-2030)
  • Figure 6: Spirometers Market in Global by End-User (2021-2030)
  • Figure 7: Spirometers Market in Global by Geography (2021-2030)
  • Figure 8: Spirometers Market in North America (2021-2030)
  • Figure 9: Spirometers Market in the United States (2021-2030)
  • Figure 10: Spirometers Market in Canada (2021-2030)
  • Figure 11: Spirometers Market in Mexico (2021-2030)
  • Figure 12: Spirometers Market in Europe (2021-2030)
  • Figure 13: Spirometers Market in France (2021-2030)
  • Figure 14: Spirometers Market in Germany (2021-2030)
  • Figure 15: Spirometers Market in United Kingdom (2021-2030)
  • Figure 16: Spirometers Market in Italy (2021-2030)
  • Figure 17: Spirometers Market in Spain (2021-2030)
  • Figure 18: Spirometers Market in the Rest of Europe (2021-2030)
  • Figure 19: Spirometers Market in Asia-Pacific (2021-2030)
  • Figure 20: Spirometers Market in China (2021-2030)
  • Figure 21: Spirometers Market in Japan (2021-2030)
  • Figure 22: Spirometers Market in India (2021-2030)
  • Figure 23: Spirometers Market in Australia (2021-2030)
  • Figure 24: Spirometers Market in South Korea (2021-2030)
  • Figure 25: Spirometers Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Spirometers Market in the Rest of the World (2021-2030)
  • Figure 27: Spirometers Market in the Middle East (2021-2030)
  • Figure 28: Spirometers Market in Africa (2021-2030)
  • Figure 29: Spirometers Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis